Supernus Announces Proposed Private Offering of $350 Million of Convertible Senior Notes

World News: . []

ROCKVILLE Md March 13 2018 GLOBE NEWSWIRE -- Supernus Pharmaceuticals Inc NASDAQSUPN the Company a specialty pharmaceutical company focused on developing and commercializing products for the treatment of central nervous system disease...

More news and information about Supernus Pharmaceuticals, Inc.

Published By:

Globe Newswire: 20:01 GMT Tuesday 13th March 2018

Published: .

Search for other references to "supernus" on SPi News


Previous StoryNext Story

SPi News is published by Sector Publishing Intelligence Ltd.
© Sector Publishing Intelligence Ltd 2018. [Admin Only]
Sector Publishing Intelligence Ltd.
Agriculture House, Acland Road, DORCHESTER, Dorset DT1 1EF United Kingdom
Registered in England and Wales number 0751938.
Privacy Policy | Terms and Conditions | Contact Us